ArticleCancer biomarkers : section A of Disease markers2025
Polyclonal plasma cell (PolyPC) signature as a key indicator for predicting the progression of MGUS to multiple myeloma.
Fumou Sun et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.